Filing Details

Accession Number:
0001598577-14-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-27 14:11:24
Reporting Period:
2014-08-26
Filing Date:
2014-08-27
Accepted Time:
2014-08-27 14:11:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400482 Acucela Inc. M?????? Pharmaceutical Preparations (2834) 020592619
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598577 Hien Deyoung C/O Acucela Inc.
1301 Second Ave., Suite 1900
Seattle WA 98101
Vp Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-26 40,000 $3.23 40,000 No 4 M Direct
Common Stock Acquisiton 2014-08-26 16,800 $4.52 56,800 No 4 M Direct
Common Stock Disposition 2014-08-26 56,800 $7.89 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-08-26 40,000 $0.00 40,000 $3.23
Common Stock Stock Option (right to buy) Disposition 2014-08-26 16,800 $0.00 16,800 $4.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-28 No 4 M Direct
11,200 2021-07-21 No 4 M Direct
Footnotes
  1. The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192000).
  2. The shares were sold at a price of 820.4909 Japanese Yen. The U.S. per share price reflects the average of the buy and sell Japanese Yen-to-U.S. Dollar exchange rates on the transaction date divided by the number of shares sold.
  3. The option was 100% vested and was exercisable on September 1, 2012.
  4. The option vests and is exercisable at the rate of 1/5th of the total shares on July 1, 2012 and then an additional 1/5th yearly thereafter, with 100% vested and exercisable on July 1, 2016, subject to the reporting person's provision of service to the issuer on each reporting date.